publishing solutions - future medicine · enago we partner with enago to offer presubmission...

For more information visit www.future-science-group.com

FUTURE SCIENCE GROUPPUBLISHING SOLUTIONS

For more information go to www.future-science-group.com2

3For more information visit www.future-science-group.com

CONTENTS

About Future Science Group...............................................................................................

Editorial Boards............................................................................................... Future Medicine At-A-Glance...............................................................................................

Future Science At-A-Glance...............................................................................................

How To Publish With FSG...............................................................................................

Readership Breakdown...............................................................................................

Comprehensive Coverage...............................................................................................

Open Access...............................................................................................

Accelerated Publication...............................................................................................

Making The Most Of Your Article...............................................................................................

13

14

4

5

6

7

8

10

11

12

http://www.future-science-group.com

4

ABOUT FUTURE SCIENCE GROUP

Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses two imprints; Future Medicine and Future Science. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded, EMBASE, Chemical Abstracts and Scopus.

OUR PUBLISHING PROCESSFSG upholds the highest standards of editorial integrity, including disclosure and independent peer review. We adhere to the guidelines set by COPE and ICMJE, endorse CONSORT, and follow the recommendations set by GPP3, ensuring our authors and readers are in safe hands. Our publishing process is reassuringly rigorous, with a minimum of three experts (one in-house specialist and a minimum of two external) reviewing each paper. With an in-house, London-based editorial team, there is a specialist point of contact available at all times available to answer any presubmission enquires and provide updates on your paper throughout the publication process. Both solicited and unsolicited articles are considered for publication, ensuring each journal provides the most up-to-date research and opinion within it’s field. We also consider company-funded research written by academic and industry authors.



5

EDITORIAL BOARDS

• Karolinska Institute, Sweden• Kyoto University, Japan• Cancer Research, UK

EDITORIAL BOARDS All journals are supported by their international Editorial Boards, who assist with the journal content and provide guidance on the peer review of submitted articles.

Our Editorial Board members represent the world’s most prestigious organizations, including:

• Cambridge University, UK• Harvard University, USA• Monash University, Australia


Biomarkers in Medicine is a premier forum for dissemination of new knowledge in biomarkers science and practice. The journal provides an authoritative vehicle across biomedical specialties spanning the

spectrum of discovery, translation and application

Andre Terzic, Mayo Clinic College of Medicine, USA– Senior Editor, Biomarkers in Medicine

Future Oncology has both cutting edge articles and well-written reviews to assist the oncologists who see themselves as being early

adopters of novel approaches as well as experienced oncology specialists.

Adam Dicker, Thomas Jefferson University, USA – Senior Editor, Future OncologyRest of the World

14%

North America 47% Europe 39% “

“

”

”


6

FUTURE MEDICINE AT-A-GLANCE

Journal MEDLINE-indexed Impact Factor (2016)

Frequency (per year)

(NEW) Bioelectronics in Medicine No n/a 4

Biomarkers in Medicine Yes 2.02 12

Breast Cancer Management No n/a Rolling

CNS Oncology Yes n/a Rolling

Colorectal Cancer No n/a Rolling

Concussion No n/a Rolling

Epigenomics Yes 4.54 12

Future Cardiology Yes n/a 6

Future Microbiology Yes 3.38 16

Future Neurology No n/a 4

Future Oncology Yes 2.13 30

Future Virology No 0.96 12

Hepatic Oncology No n/a Rolling

Immunotherapy Yes 2.72 16

International Journal of Endocrine Oncology No n/a Rolling

International Journal of Hematologic Oncology No n/a Rolling

Journal of 3D Printing in Medicine No n/a 4

Journal of Comparative Effectiveness Research Yes 1.20 8

Lung Cancer Management No n/a Rolling

Melanoma Management No n/a Rolling

Nanomedicine Yes 4.73 24

Neurodegenerative Disease Management Yes n/a 6

Pain Management Yes n/a 6

Personalized Medicine No 1.01 6

Pharmacogenomics Yes 2.35 18

Regenerative Medicine Yes 2.87 8

= Open Access



7

Journal MEDLINE-indexed Impact Factor (2016) Frequency (per year)Bioanalysis Yes 2.67 24

Future Medicinal Chemistry Yes 3.56 24

Future Science OA PMC-indexed n/a Rolling

International Journal of Pharmacokinetics No n/a 4

Pharmaceutical Patent Analyst Yes n/a 6

Therapuetic Delivery Yes n/a 12

FUTURE SCIENCE AT-A-GLANCE

= Open Access

PMC = Pubmed Central



8

Presubmissionenquiries welcome

Peer-review

Article accepted

Author revisionsArticle submitted

Choose whether to publish via our standard or accelerated publication routes

Note: formatting isn't compulsory at this stage

You can track the progress of your article via our submission site

Social media promotion

Reprints and ePrints

Altmetrics

Open accessPromotion via our

digital hubs

[email protected]

You can submit your article online

Don’t forget!

Don’t forget!

You will need a signed authordisclosure form

You will need a signed copyright form/OA license form

STANDARD PUBLICATION in 14–16 weeks

ACCELERATED PUBLICATION in 6 weeks

ZONE

Publi

shed

Online

!

HOW TO PUBLISH WITH FSG



9

Presubmissionenquiries welcome

Peer-review

Article accepted

Author revisionsArticle submitted

Choose whether to publish via our standard or accelerated publication routes

Note: formatting isn't compulsory at this stage

You can track the progress of your article via our submission site

Social media promotion

Reprints and ePrints

Altmetrics

Open accessPromotion via our

digital hubs

[email protected]

You can submit your article online

Don’t forget!

Don’t forget!

You will need a signed authordisclosure form

You will need a signed copyright form/OA license form

STANDARD PUBLICATION in 14–16 weeks

ACCELERATED PUBLICATION in 6 weeks

ZONE

Publi

shed

Online

!



10

FUTURE MEDICINEwww.futuremedicine.com26 JournalsLast 12 months: • 24 million abstract views • >1 million + full-text downloadsGlobal coverage

FUTURE SCIENCEwww.future-science.com6 JournalsLast 12 months: • 625,000 abstract views • 375,000 full-text downloadsGlobal coverage

READERSHIP BREAKDOWN

Rest ofthe World40%

North America 33%Europe 26%

READERSHIPOur journal readership spans specialists in bioscience and medicine across the globe.Our key reader groups are:

Clinical, basic and translational researchers in academia, industry, hospitals and government research organizations

Clinicians in primary and secondary careincluding: cardiologists, neurologists, oncologists and infectious disease specialists

Policy and decision makersin government and industry and those with an interest in pharmaceutical patents/intellectual property



11

COMPREHENSIVE COVERAGE

Whether you’re looking to publish clinical trial results, describe the design of a new study or provide an in-depth review, our team will support you fully before, during and after publication.

We are happy to work with both academic key opinion leaders as well as industry authors, as we recognise they are also among the leading experts in their field.

In addition to offering presubmission advice, we will assist you with journal selection for a broad range of article types, including:

ORIGINAL RESEARCH• Pre- and post-registration studies• Comparative effectiveness research• Observational studies• Clinical trial protocols and methodologies• Cost-effectiveness/HEOR studies• Negative data• Evidence-based medicine and real-world data• Patient-reported outcomes

REVIEWS• Narrative reviews• Systematic reviews• Unmet medical needs• Multidisciplinary approaches to care• Consensus and treatment guidelines• Management perspectives• Therapeutic overviews• Drug, device and vaccine evaluations• Commentaries on key clinical studies



12

OPEN ACCESS

Publishing an article Open Access increases the readers it is able to reach, along with the recognition for you and your organization. Open Access articles have significantly higher readership than articles behind the subscription barrier.

All FSG subscription journals offer an Open Access option. FSG also publishes ten fully Open Access journals:

Authors can opt for our Gold Open Access option (CC BY) in these ten journals, allowing unrestricted access to the online version of their article. This option is available for all article types except Drug Evaluation and Device Evaluation articles. We also offer reduced Open Access fees for articles 12 months or older.



13

ACCELERATED PUBLICATION

Our typical publication times from submission to acceptance are 14 to 16 weeks as standard (pending successful peer review).

However, if you require earlier publication, or by a specific date, you can publish in as little as 6 weeks through our Accelerated Publication service.

Accelerated Publication could help you stay ahead of the competition, or allow you to get some vital content out before an important conference. It will maximise the impact of your scientific endeavour, ensuring swifter access to your latest findings.

A fee per published page applies, and publication is, of course, still subject to approval following independent peer review.

Submission

Week 1

Week 2

Week 3

Week 4

Week 5

Online publication

Peerreview

Author revision

Authorapproval

Production



14

MAKING THE MOST OF YOUR ARTICLE

ARTICLE METRICSLeveraging both the Altmetric and Atypon platforms, we are able to provide granular article-level metrics for all our articles. Authors can look at the conversations around their paper as well as usage data, making it easy for them to measure the impact and reach of their article. Authors are also encouraged to boost the reach of their research via our partnership with Kudos.

DIGITAL ENHANCEMENTSTo help meet your goals, we can enrich your research with digital options on our web platforms including:

• Audio/video abstracts • Graphical abstracts

Enhancing the value of our publications, we also have digital hubs, featuring journal articles as well as expert interviews and bespoke content. By featuring your article on our hubs you can further your reach to highly engaged groups.

ENAGOWe partner with Enago to offer presubmission editing services, including English editing and proofreading of scientific manuscripts for authors for whom English is a second language.

For further information please go to: http://futuremedicine.enago.com and http://futurescience.enago.com

KUDOSFSG partners with Kudos to bring our authors online tools to increase the reach of their work. Kudos provides an independent, cross-publisher platform for researchers to explain and share their work with wider audiences, and to track the impact this has on downloads, citations and altmetrics.

For more information go to: www.futuremedicine.com/kudos or www.future-science.com/kudos

• Infographics and article snapshots• Mechanism of action videos


http://futuremedicine.enago.com

http://futurescience.enago.com

http://www.futuremedicine.com/kudos

http://www.future-science.com/kudos


15

MAKING THE MOST OF YOUR ARTICLE

REPRINTSOur dedicated in-house account managers are available throughout the publication process to discuss the dissemination of your research. Reprints and ePrints are available in quantities as few as 100 copies.

SOCIAL MEDIAAll of our journals are integrated with Twitter, and many of our journals have sizeable LinkedIn groups. To maximise the impact of your article we can target niche groups with posts exclusively devoted to your work.

SPONSORED ACCESSSponsors or third parties wishing to make an article free to download from our website can provide access by paying the appropriate Sponsored Access fee. More information on the Sponsored Access option is available upon request.

SUPPLEMENTSAn ideal way to provide focused, added-value content for your target audience. Content may comprise:

• Symposia proceedings • Abstract compilations• Workshop summaries

All supplements follow the same standards of editorial integrity adopted by our journals, including disclosure, independent review and publication guideline adherence (ICMJE/GPP3). Publication times are flexible depending on your needs and supplements can be published as early as 4 weeks from acceptance.

• Roundtable discussions• Article collections




Contact usFuture Science GroupUnitec House2 Albert PlaceLondon, N3 1QBUnited Kingdom

Joanne Walker( +44(0)20 8371 6090* [email protected]

8 www.future-science-group.com @futuresciencegp

future-science-groupFuture Science Group


http://twitter.com/futuresciencegp

http://en-gb.facebook.com/futuresciencegroup

http://uk.linkedin.com/company/future-science-group

publishing solutions - future medicine · enago we partner with enago to offer presubmission...

Documents